Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases.
Head and neck cancer
Non-coplanar radiotherapy
OAR sparing
Treatment planning
VMAT
Journal
Radiation oncology (London, England)
ISSN: 1748-717X
Titre abrégé: Radiat Oncol
Pays: England
ID NLM: 101265111
Informations de publication
Date de publication:
15 Jul 2022
15 Jul 2022
Historique:
received:
18
12
2021
accepted:
30
06
2022
entrez:
15
7
2022
pubmed:
16
7
2022
medline:
20
7
2022
Statut:
epublish
Résumé
Dynamic trajectory radiotherapy (DTRT) extends volumetric modulated arc therapy (VMAT) with dynamic table and collimator rotation during beam-on. The aim of the study is to establish DTRT path-finding strategies, demonstrate deliverability and dosimetric accuracy and compare DTRT to state-of-the-art VMAT for common head and neck (HN) cancer cases. A publicly available library of seven HN cases was created on an anthropomorphic phantom with all relevant organs-at-risk (OARs) delineated. DTRT plans were generated with beam incidences minimizing fractional target/OAR volume overlap and compared to VMAT. Deliverability and dosimetric validation was carried out on the phantom. DTRT and VMAT had similar target coverage. For three locoregionally advanced oropharyngeal carcinomas and one adenoid cystic carcinoma, mean dose to the contralateral salivary glands, pharynx and oral cavity was reduced by 2.5, 1.7 and 3.1 Gy respectively on average with DTRT compared to VMAT. For a locally recurrent nasopharyngeal carcinoma, D This study provides a proof of principle of DTRT for common HN cases with plans that were deliverable on a C-arm linac with high accuracy. The comparison with VMAT indicates substantial OAR sparing could be achieved.
Sections du résumé
BACKGROUND
BACKGROUND
Dynamic trajectory radiotherapy (DTRT) extends volumetric modulated arc therapy (VMAT) with dynamic table and collimator rotation during beam-on. The aim of the study is to establish DTRT path-finding strategies, demonstrate deliverability and dosimetric accuracy and compare DTRT to state-of-the-art VMAT for common head and neck (HN) cancer cases.
METHODS
METHODS
A publicly available library of seven HN cases was created on an anthropomorphic phantom with all relevant organs-at-risk (OARs) delineated. DTRT plans were generated with beam incidences minimizing fractional target/OAR volume overlap and compared to VMAT. Deliverability and dosimetric validation was carried out on the phantom.
RESULTS
RESULTS
DTRT and VMAT had similar target coverage. For three locoregionally advanced oropharyngeal carcinomas and one adenoid cystic carcinoma, mean dose to the contralateral salivary glands, pharynx and oral cavity was reduced by 2.5, 1.7 and 3.1 Gy respectively on average with DTRT compared to VMAT. For a locally recurrent nasopharyngeal carcinoma, D
CONCLUSIONS
CONCLUSIONS
This study provides a proof of principle of DTRT for common HN cases with plans that were deliverable on a C-arm linac with high accuracy. The comparison with VMAT indicates substantial OAR sparing could be achieved.
Identifiants
pubmed: 35841098
doi: 10.1186/s13014-022-02092-5
pii: 10.1186/s13014-022-02092-5
pmc: PMC9284789
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122Informations de copyright
© 2022. The Author(s).
Références
J Neurosurg. 2000 Dec;93 Suppl 3:219-22
pubmed: 11143252
Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):606-617
pubmed: 29413274
Radiother Oncol. 2006 Nov;81(2):151-7
pubmed: 17055095
Radiother Oncol. 2018 Jan;126(1):25-36
pubmed: 29153464
Br J Radiol. 2018 Dec;91(1092):20180270
pubmed: 30074813
Phys Med Biol. 2018 Jan 16;63(2):025023
pubmed: 29336348
Radiother Oncol. 2014 Mar;110(3):390-7
pubmed: 24721546
Med Phys. 2018 Jul 10;:
pubmed: 29992574
Phys Med Biol. 2013 Nov 21;58(22):8163-77
pubmed: 24200876
Acta Oncol. 2015 Feb;54(2):283-7
pubmed: 25029286
Radiother Oncol. 2019 May;134:1-9
pubmed: 31005201
Radiother Oncol. 2015 Feb;114(2):230-8
pubmed: 25701297
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1002-1011
pubmed: 28721881
Radiat Oncol. 2020 Jul 8;15(1):164
pubmed: 32641082
Phys Med Biol. 2015 Jul 07;60(13):5179-98
pubmed: 26083759
Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):401-9
pubmed: 25482301
Med Phys. 2008 Jan;35(1):310-7
pubmed: 18293586
Med Phys. 2015 Nov;42(11):6457-67
pubmed: 26520735
Lancet Oncol. 2012 Feb;13(2):145-53
pubmed: 22261362
Med Phys. 1998 May;25(5):656-61
pubmed: 9608475
Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):567-580
pubmed: 31276776
Lancet Oncol. 2011 Feb;12(2):127-36
pubmed: 21236730
Med Phys. 2015 Jan;42(1):416-29
pubmed: 25563282
Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1238-47
pubmed: 21377811
Med Phys. 2012 Oct;39(10):6339-50
pubmed: 23039670
Med Phys. 2015 May;42(5):2157-68
pubmed: 25979010
Radiat Oncol J. 2020 Jun;38(2):138-147
pubmed: 33012157
Med Phys. 2020 Jul;47(7):3078-3090
pubmed: 32215936
Radiother Oncol. 2015 Jun;115(3):285-94
pubmed: 26094076
Support Care Cancer. 2008 Feb;16(2):171-9
pubmed: 17618467
Radiother Oncol. 2021 Mar;156:281-293
pubmed: 33515668
Med Phys. 2011 May;38(5):2523-34
pubmed: 21776787
Radiat Oncol J. 2020 Mar;38(1):11-17
pubmed: 32229804
J Appl Clin Med Phys. 2017 Sep;18(5):293-300
pubmed: 28834021
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S28-35
pubmed: 20171514
Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):337-43
pubmed: 26264629
Phys Med Biol. 2019 Apr 05;64(8):08NT01
pubmed: 30808011
Radiother Oncol. 2018 Jan;126(1):3-24
pubmed: 29180076
Phys Med Biol. 2018 Jul 02;63(13):135014
pubmed: 29863493
Curr Opin Otolaryngol Head Neck Surg. 2017 Jun;25(3):211-216
pubmed: 28277333
Cancer. 2004 May 1;100(9):1786-92
pubmed: 15112257
Radiother Oncol. 2020 Dec;153:67-78
pubmed: 32976873
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):103-11
pubmed: 15629600
Med Phys. 2018 Jul 10;:
pubmed: 29992587
Radiother Oncol. 2020 Feb;143:24-29
pubmed: 32044165
Lancet Oncol. 2021 Mar;22(3):381-390
pubmed: 33600761
Radiother Oncol. 2009 Nov;93(2):259-65
pubmed: 19748146
Br J Radiol. 2019 May;92(1097):20180908
pubmed: 30694086
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):348-54
pubmed: 23312272
Z Med Phys. 2019 Feb;29(1):31-38
pubmed: 29631759
Med Dosim. 2019 Winter;44(4):394-400
pubmed: 30827765
Med Phys. 2017 Jul;44(7):3375-3392
pubmed: 28397968